June 11, 2025

PPV Glaucoma Risk

Study observes risk of pars plana vitrectomy patients developing glaucoma within five years of procedure

The Ophthalmologist

June 02, 2025

Optical Coherence Tomography Angiography and Glaucoma

A patient with a history of LASIK and glaucoma receives treatment with latanoprost despite challenges in adjusting intraocular pressure due to corneal thinning post-refractive surgery. Optic nerve and macular thinning, visual field defects, and perfusion loss raise concerns for long-term prognosis.

Optometric Management

June 01, 2025

Strategies for Successful Glaucoma Comanagement

Glaucoma management is a lifelong endeavor that requires consistent monitoring, timely intervention, and patient adherence. Comanagement of glaucoma involving optometrists and ophthalmologists has emerged as a highly effective approach that can enhance patient outcomes, streamline care delivery, and foster professional satisfaction for both providers.

Glaucoma Physician

May 19, 2025

Test Your Diagnostic Skills using OCT and Fundus Imaging

Test Your Diagnostic Skills using OCT and Fundus Imaging

The Ophthalmologist

April 27, 2025

Office-Based Therapies Gain Ground in Glaucoma Care

Selective laser trabeculoplasty and sustained drug delivery are essential tools in the interventional glaucoma paradigm.

Ophthalmology Management

March 12, 2025

LiGHT Trial Data Shows Efficacy in Decreasing Medication Burden with SLT

60.5% of eyes required no further medical or surgical treatment after 3 years of eye drop use when patients switched to SLT.

Conexiant

May 01, 2025

Glaucoma: A Toxic Relationship

Several studies do establish diabetes as a risk factor for glaucoma, and that diabetes with coexisting glaucoma increases the risk of developing diabetic retinopathy.

Optometric Management

August 27, 2024

PCPs Play Important Role in Glaucoma Screening

“Recommendations from trusted primary providers have likely kept millions of individuals from becoming blind.”

Conexiant

February 14, 2025

Researchers Make the Case for Multimodal, Multimechanism Glaucoma Therapy

"Evidence shows that many patients require more than one treatment to achieve adequate IOP reduction and glaucoma control."

Conexiant